Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

162 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Completed

The Norwegian Nucleoside Analogue Stop Study

NCT03681132

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Hvidovre Hospital Copenhagen, Denmark
  • St Paul Hospital Millennium Medical College Addis Ababa, Ethiopia
  • Ålesund Hospital Ålesund, Norway
  • Bodø Hospital Bodø, Norway
View Trial Details
Completed

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

NCT01519960

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Univ of California SF, Benioff Children's Hospital; Pediatrics, Gastro, Hepatology & Nutrition San Francisco, California, United States
  • Johns Hopkins Hospital - Pediatric Gastroenterology Baltimore, Maryland, United States
  • Children's Hospital Boston-Harvard Medical School; Division of Gastoenterology Boston, Massachusetts, United States
  • St. Louis University - Cardinal Glennon Children's Medical Center St Louis, Missouri, United States
View all 39 locations
View Trial Details
Completed

A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir

NCT04365933

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • ENYO PHARMA Investigative site HK01 Hong Kong
  • ENYO PHARMA Investigative site KR01 Busan, South Korea
  • ENYO PHARMA Investigative site TW03 Kaohsiung City, Taiwan
  • ENYO PHARMA Investigative site TW04 Kaohsiung City, Taiwan
View Trial Details
Completed

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

NCT02224456

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +24 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Wuhan, Hubei, China
  • GSK Investigational Site Nanjing, Jiangsu, China
  • GSK Investigational Site Nanjing, Jiangsu, China
View all 19 locations
View Trial Details
Completed

Safety and Acceptability of a Vaginal Microbicide

NCT00111943

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +24 more
Locations
  • Alabama Microbicide CRS Birmingham, Alabama, United States
  • Bronx- Lebanon Hospital Center Clinical Research Site (BLHC CRS) The Bronx, New York, United States
  • NARI Arogya Aadhar Clinic CRS Pune, Maharashtra, India
View Trial Details
Completed

A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

NCT04248426

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Altasciences Montreal, Quebec, Canada
  • Republican Clinical Hospital "Timofei Mosneaga" Arensia EM Unit Chisinau, Republic of Moldova, Moldova
  • Medical Center of Limited Liability Company "Harmoniya krasy" Department of Clinical Trials Kyiv, Ukraine
View Trial Details
Completed

A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically Suppressed

NCT03463369

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • ZiekenhuisNetwerk Antwerpen (ZNA) - Stuivenberg Antwerp, Belgium
  • Universite Catholique de Louvain (UCL) - Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universite Libre de Bruxelles (ULB) - Hopital Erasme Brussels, Belgium
  • Ruprecht-Karls-U Mannheim Mannheim, Baden-Wurttemberg, Germany
View all 14 locations
View Trial Details

Related conditions